Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing the 40,000 busiest of 45,791 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Asia-Pacific | 45,791 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 306,670 |
| Germany | 73,127 |
| France | 73,097 |
| Italy | 48,361 |
| China | 45,791 |
| Japan | 38,701 |
| Spain | 36,382 |
| United Kingdom | 32,384 |
Trial sites
45,791 sites. Sites with a public page link to it on Pharma Observatory.
-
Nanfang Hospital 127 trials
-
Zhongshan Hospital 126 trials
-
Jiangsu Province Hospital 124 trials
-
Peking University Cancer Hospital 123 trials
-
Xiangya Hospital Central South University 123 trials
-
Yantai Yuhuangding Hospital 122 trials
-
Beijing Hospital 119 trials
-
The Second Hospital of Jilin University 118 trials
-
Shanghai East Hospital 117 trials
-
Wuhan Union Hospital 117 trials
-
Nanjing Drum Tower Hospital 116 trials
-
First Hospital of Jilin University 114 trials
-
Hangzhou First People's Hospital 114 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.